Hemoglobinopathy Nursing Program and Pediatric Nursing Students

Sponsor

Beni-Suef University (Other)

Overall Status

Completed

CT.gov ID

NCT05389891

Collaborator

Benha University (Other)

108

Enrollment

Location

Arms

2.4

Actual Duration (Months)

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Hemoglobinopathies are the most common life threatening, monogenic disorders in the world.

The most common causes of hemoglobinopathies are sickle cell disease and thalassemia. Aim:

This study aimed to evaluate the effect of a hemoglobinopathy nursing program on pediatric nursing students' performance.

Condition or Disease	Intervention/Treatment	Phase
Hemoglobinopathies Thalassemia Sickle Cell Disease Nurse's Role	Other: Hemoglobinopathy Nursing Program	N/A

Study Design

Study Type:

Interventional

Actual Enrollment :

108 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

Single (Participant)

Primary Purpose:

Treatment

Official Title:

Effect of a Hemoglobinopathy Nursing Program on Pediatric Student Nurses' Awareness and Performance

Actual Study Start Date :

Feb 27, 2017

Actual Primary Completion Date :

Apr 26, 2017

Actual Study Completion Date :

May 11, 2017

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Group 1 Experimental Group (n=54) The implementation phase was achieved through sessions within Feb-April2017 second semester of the academic year 2016/2017.Each session started by the objectives of the new session and summary of previous one. Motivation and reinforcement during session were used to enhance participation and sharing in this study. The researcher did the explanation of the questionnaire sheet to the pediatric student nurses to assess their awareness and attitude toward hemoglobinopathies. The researcher observed the pediatric student nurses 'practice during applying blood transfusion, subcutaneous medication administration, and oral medication administration using the observational checklist at faculty laboratory.	Other: Hemoglobinopathy Nursing Program "Hemoglobinopathy Nursing Program" is more informative for "Groupe 1" than "Group 2"
No Intervention: Group 2 Control Group (n=54) The researcher did the explanation of the questionnaire sheet to the pediatric student nurses to assess their awareness and attitude toward hemoglobinopathies. The researcher observed the pediatric student nurses 'practice during applying blood transfusion, subcutaneous medication administration, and oral medication administration using the observational checklist at faculty laboratory.

Arm

Intervention/Treatment

Experimental: Group 1

Experimental Group (n=54) The implementation phase was achieved through sessions within Feb-April2017 second semester of the academic year 2016/2017.Each session started by the objectives of the new session and summary of previous one. Motivation and reinforcement during session were used to enhance participation and sharing in this study. The researcher did the explanation of the questionnaire sheet to the pediatric student nurses to assess their awareness and attitude toward hemoglobinopathies. The researcher observed the pediatric student nurses 'practice during applying blood transfusion, subcutaneous medication administration, and oral medication administration using the observational checklist at faculty laboratory.

Other: Hemoglobinopathy Nursing Program

"Hemoglobinopathy Nursing Program" is more informative for "Groupe 1" than "Group 2"

No Intervention: Group 2

Control Group (n=54) The researcher did the explanation of the questionnaire sheet to the pediatric student nurses to assess their awareness and attitude toward hemoglobinopathies. The researcher observed the pediatric student nurses 'practice during applying blood transfusion, subcutaneous medication administration, and oral medication administration using the observational checklist at faculty laboratory.

Outcome Measures

Primary Outcome Measures

Pediatric nursing students' awareness [10 weeks]
Measure Students' awareness through: 01. Personal Data and PNSs' Awareness Questionnaire -sixty (60) questions. A score of (one) for correct answers, and (zero) for the wrong answers. The total scores ranged from (0-60 mark).
Pediatric nursing students' Attitude [10 weeks]
Pediatric nursing students' Attitude Scale - nine (9) questions. A five-point Likert scale by give a score of (four) for Strongly Agree, (three) for Agree, (two) for Undecided, (one) for Disagree and (zero) for Strongly Disagree. The total score ranged from (0-36 mark).
Pediatric nursing students' Practice [10 weeks]
Observational Checklists - forty (40) items. A score of (two) for completely done, (one) for incompletely done and (zero) for not done. The total score ranged from (0-80 mark), scores less than 60% were considered incompetent practice.

Eligibility Criteria

Criteria

Ages Eligible for Study:

19 Years to 22 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

pediatric nursing students registered for the academic year 2016/2017

Exclusion Criteria:

Any student had personal or family history of hemoglobinopathies

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Benha University	Banhā	Other	Egypt	13511

Sponsors and Collaborators

Beni-Suef University
Benha University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Ahmed Loutfy, Principal Investigator, Beni-Suef University

ClinicalTrials.gov Identifier:

NCT05389891

Other Study ID Numbers:

PediaMarch201601

First Posted:

May 25, 2022

Last Update Posted:

May 25, 2022

Last Verified:

May 1, 2022

Individual Participant Data (IPD) Sharing Statement:

Yes

Plan to Share IPD:

Yes

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Anemia, Sickle Cell

Thalassemia

Hemoglobinopathies

Study Results

No Results Posted as of May 25, 2022